new therapeutic aspects therefore are mentioned : the blockade of aggregation and the release syndrome by adding aspirin , aprotinin or prostaglandin e 1 to the stored blood , pharmacologically influencing the metabolism of arachidonic acid by inhibiting negative effects of prostaglandins ( injecting ibuprofen as inhibitor of thromboxane-synthesis ) and stimulating positive prostaglandin effects ( infusion of prostacyclin ) , and finally the application of fibronectin ( cryoprecipitates ) for increasing the res-function thus also enhancing the clearance of microaggregates , fibrinogen/fibrin complexes and intestinal serotonin .
C0033559
prostaglandin e
C0033554
prostaglandin